Delivery Order SPE2DR25D1106-SPE2DR26FJA4A
- Not listed
- The Defense Logistics Agency awarded a $2,172.10 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Provayblue 50 mg/10 ml vials. This firm fixed price contract, with an ultimate completion date of September 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award involves no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $2,023.70 to AmerisourceBergen Drug Corp for the supply of Provayblue 50 mg/10 ml ampules on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,838.40 firm fixed-price delivery order is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML pharmaceutical products. The fixed-price delivery order, valued at $5,973.29, has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,399.56, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC enables efficient government procurement of essential pharmaceutical and medical supplies to support military healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,361.72, is a Firm Fixed Price Delivery Order for the supply of PROVAYBLUE 50 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $5,514.25 to AmerisourceBergen Drug Corp on November 11, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $158,944.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The work will be...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJA4ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,489.65 to AmerisourceBergen Drug Corp for the supply of Provayblue 50 mg/10 ml ampules on November 20, 2025. This firm fixed-price contract, with an ultimate completion date of November 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded through the federal procurement process. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a significant prime IDC valued at $999,999,999.00 through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company regularly fulfills delivery orders for specialized medications, vaccines, and medical commodities across multiple therapeutic domains through the DLA Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies AmerisourceBergen's role as a key pharmaceutical supplier supporting federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/20/25 |